CAIV-T, Liquid

BIOLOGICAL3 trials

Sponsors

MedImmune LLC

Conditions

HealthyInfluenza

Phase 2

Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)

CompletedNCT00192387

MedImmune LLCInfluenza

Start: 2001-09-30End: 2001-12-31Target: 60Updated: 2021-09-13

Phase 3

Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children

CompletedNCT00192374

MedImmune LLCHealthy

Start: 2002-02-28End: 2002-11-30Target: 1920Updated: 2006-10-03

Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine, Trivalent, Types A & B, Live, Cold-Adapted (CAIV-T) in Healthy Children

CompletedNCT00192244

MedImmune LLCHealthy

Start: 2000-09-30End: 2002-10-31Target: 3000Updated: 2006-10-03